Clinical Pharmacology Quality Assurance (CPQA)
- Institution
- STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY
- Principal investigator
- Gene Morse
- Funding
- $1.8M
- Duration
- 2025–2026
Moonbase score
Still being scored
Abstract
The purpose of NIAID Clinical Pharmacology Quality Assurance (CPQA) Program is to provide a comprehensive quality assessment program for clinical pharmacologic laboratories testing samples from subjects enrolled in NIAID-supported clinical studies. The CPQA Program ensures the validity and inter- and intra-laboratory comparability of pharmacological study data by providing laboratories with materials for pharmacology proficiency testing and assay controls, and monitoring proficiency and assay data from each laboratory. The program also develops and implements standards of performance for new pharmacology assays, develops and tests methods relating to the assays, and acquires, tests, stores, and dispenses quality control materials and reagents. Thus, the CPQA Program is critical to the scientific integrity of on-going and future studies concerning the assessment of therapeutic and prevention measures for HIV and other infectious diseases.
LOADING MOONBASE SCORE
Questions for STATE UNIVERSITY OF NEW YORK AT BUFFALO
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · State University of New York at Buffalo48
Bacterial sialometabolic activity impacts periodontal immunity and microbiota
Ashu Sharma · $379K · 2020–2026
- NIH · State University of New York at Buffalo46
Model-aided Design and Integration of Functionalized Hybrid Nanomaterials for Enhanced Bioremediation of Per-and Polyfluoroalkyl Substances (PFASs)
Diana S Aga · $282K · 2021–2025
- NIH · State University of New York at Buffalo43
Role of cardiac clock misalignment in promoting arrhythmias in swine and donor human hearts
Kedar Kirtikumar Aras · $721K · 2025–2030